Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06122090
PHASE2

Treatment of Hypopigmented Scars With Bimatoprost

Sponsor: Medstar Health Research Institute

View on ClinicalTrials.gov

Summary

Patients who have hypo-pigmented burn scar will have two scars chosen and randomized to treated scar and control scar. The subject will then have both scars treated with fractional ablative CO2 laser (FLSR). The treated scar will have bimatoprost delivered through the laser channels, while the control will have the vehicle (normal saline) only delivered. The treatment will continue for 14 days with twice daily application. The scars will then be monitored at a 2-week follow-up visit where levels of melanin will be evaluated. Tissue punch biopsies will also be used to evaluate the mechanism of action of bimatoprost. Treatment will occur for 6 sessions at 4-6 week intervals including follow- up visits and evaluations.

Official title: Evaluation of Laser-assisted Drug Delivery of Bimatoprost for the Treatment of Hypertrophic Scar Hypopigmentation: A Within Patient-Controlled Trial in Skin of Color

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2023-07-18

Completion Date

2025-07-31

Last Updated

2024-05-03

Healthy Volunteers

No

Interventions

DRUG

Bimatoprost

Bimatoprost will be delivered with laser

DRUG

Saline

Saline control will be delivered with laser

Locations (1)

MedStar Washington Hospital Center

Washington D.C., District of Columbia, United States